Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lead PTP1B inhibitor with blood glucose-lowering effects identified by Korean group

June 20, 2002

Preclinical findings reported for aldose reductase inhibitor fidarestat

June 20, 2002

New data on ragaglitazar discussed at the ADA scientific sessions

June 20, 2002

NN-2211 may be useful for treating obesity and type 2 diabetes

June 20, 2002

Insulin receptor activator designed by Telik reverses indinavir-induced insulin resistance

June 19, 2002

AC-2993 is an effective and safe agent for type 1 and 2 diabetes mellitus

June 19, 2002

Dose-response profile for SomatoKine in insulin-requiring type 2 diabetes patients

June 19, 2002

Insmed's oral insulin sensitizer improves glycemic control, lipid profiles and beta-cell function

June 19, 2002

Estrogen receptor modulators and their use in osteoporosis, etc.

June 19, 2002

Chromium supplementation lowers blood glucose, insulin requirements in type 2 diabetes

June 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...